FDA Amends Animal Drug Regulations Due to Sponsor Change for Follicle Stimulating Hormone

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect a change in sponsorship for a new animal drug application (NADA) for follicle stimulating hormone from Ausa International, Inc. to Therio, Inc.